Lambda, a COVID-19 'variant of interest,' reported in Houston

Houston Methodist Hospital has confirmed its first case of the Lambda coronavirus variant, the Texas hospital system announced Tuesday.
First detected in Peru in December, Lambda has been designated as "a variant of interest" by the World Health Organization, and shares mutations in common with the Gamma variant, which is dominant in Brazil. While Lambda is the predominant strain in Peru, health officials say the Delta variant is still the primary concern in the U.S.
"There's a lot more evidence that we have that Delta is much more contagious, the viral loads are much higher," Dr. Wesley Long, medical director of Diagnostic Microbiology at Houston Methodist, told ABC News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There are 185 COVID-19 patients in the Houston Methodist Hospital, as of Monday, and 85 percent have been diagnosed with the Delta variant; a majority are unvaccinated. The hospital system said there is an "alarming spike in the number of COVID-19 cases across the Houston area, with the steepest increase happening over the weekend. The increased hospitalizations add stress to many of our hospitals that are nearing capacity."
The Delta variant, first detected in India in December, has been designated by WHO as a "variant of concern" and accounts for about 83 percent of all sequenced COVID-19 cases in the U.S., Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said on Tuesday. In Texas, 51 percent of the population 12 and older is fully vaccinated.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published